Literature DB >> 1607042

Prediction of survival time after curative surgery for advanced gastric cancer.

S Moriguchi1, Y Maehara, D Korenaga, K Sugimachi, Y Hayashi, Y Nose.   

Abstract

This study was carried out to define independent prognostic factors influencing survival time and to examine the survival time of patients with advanced gastric cancer treated by curative resection. Six hundred and forty-eight patients were identified of whom 275 patients died of tumor recurrence during follow-up. Univariate analysis using Mantel-Cox analysis, indicated that tumor size, tumor location, gross appearance, degree of gastric wall invasion, lymph node metastasis and operative procedures were significant factors related to survival time (P less than 0.01 to P less than 0.05). Multivariate analysis using the Cox proportional hazard model adjusted for sex, age and other factors, suggested that tumor size (P less than 0.01, relative risk = 1.79), degree of gastric wall invasion (P less than 0.01, rr = 1.24) and lymph node metastasis (P less than 0.01, rr = 2.39) were the most independent prognostic factors statistically, although these three prognostic factors were inter-related. When the tumor is less than 5 cm and there is no serosal invasion or lymph node metastasis, then a longer survival time can be expected (88.7% at 5-years). If the tumor size exceeds 10 cm and there is invasion into neighboring structures and lymph node metastases, then survival time will be short (11.9% at 4-years).

Entities:  

Mesh:

Year:  1992        PMID: 1607042

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  The efficacy of gastrectomy for large gastric cancer.

Authors:  Osamu Kobayashi; Akira Tsuburaya; Takaki Yoshikawa; Tomohiko Osaragi; Hitoshi Murakami; Tatsuya Yoshida; Motonori Sairenji
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

2.  Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.

Authors:  Jeremy Chien; Giovanni Aletti; Alfonso Baldi; Vincenzo Catalano; Pietro Muretto; Gary L Keeney; Kimberly R Kalli; Julie Staub; Michael Ehrmann; William A Cliby; Yean Kit Lee; Keith C Bible; Lynn C Hartmann; Scott H Kaufmann; Viji Shridhar
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

3.  Predictors of long-term survival in node-positive gastric carcinoma patients with curative resection.

Authors:  Dong Yi Kim; Jae Kyoon Joo; Young Kyu Park; Seong Yeob Ryu; Young Jin Kim; Shin Kon Kim
Journal:  Langenbecks Arch Surg       Date:  2006-11-07       Impact factor: 3.445

4.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

5.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Does tumor size have an impact on gastric cancer? A single institute experience.

Authors:  Kyong Hwa Jun; Hun Jung; Jong Min Baek; Hyung Min Chin; Woo Bae Park
Journal:  Langenbecks Arch Surg       Date:  2008-09-13       Impact factor: 3.445

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.